Chemring locks down on £1bn revenue goal as global conflicts rage

Chemring has reaffirmed its goal of hitting £1bn in annual revenue by the end of the decade, as rising global defence spending helped offset production and foreign exchange headwinds. The FTSE 250 British defence contractor’s order book reached a record £1.04bn in 2024, meaning more than two-thirds of next year’s revenue forecast is already covered.

“Changing customer spending priorities in the face of increased global uncertainty and competition have resulted in the order book being at its highest level in Chemring’s history, giving us a strong and sustainable platform for future growth,” Michael Ord, chief executive, said in a statement. He added the outlook for global defence markets was “increasingly robust, with strong growth expected over the decade.” Such a positive backdrop helped Chemring weather significant foreign exchange headwinds, with the group noting “volatile” exchange rates throughout the year as the US dollar, Australian dollar and Norweigian krone all weakened against the sterling.



The company has also grappled with production challenges and delays in its Tennessee Countermeasures business, which weighed on performance in the first half. Shares are trading up just three per cent this year to date despite the defence industry profiting from huge military spending worldwide following Vladimir Putin’s invasion of Ukraine and renewed conflict in the Middle East , with the Israel-Hamas war in Gaza. European Nato members are currently holding talks about increasing the alliance’s spending target to three per cent of GDP at its annual summit next June, according to a report in the Financial Times.

Chemring’s £1.04bn order book marked a 13 per cent year-on-year increase, while the Hampshire-based firm reported a three per cent rise in underlying operating profit to £71.1m.

Revenue also increased eight per cent to £510.4m over the 12 months ending 31 October, and dividend payouts are expected to rise 13 per cent to 7.8p per share.

Underlying pre-tax earnings (EBITDA) jumped six per cent to £93.7m..